4.7 Article

Network Pharmacology and Experimental Validation to Reveal the Pharmacological Mechanisms of Liuwei Dihuang Decoction Against Intervertebral Disc Degeneration

期刊

DRUG DESIGN DEVELOPMENT AND THERAPY
卷 15, 期 -, 页码 4911-4924

出版社

DOVE MEDICAL PRESS LTD
DOI: 10.2147/DDDT.S338439

关键词

intervertebral disc degeneration; Liuwei Dihuang decoction; network pharmacology; pharmacological mechanisms; apoptosis

资金

  1. National Natural Science Foundation of China [81804121, 82174140, 82174401, 82104164, 81973870, 81973881, 81904053]
  2. Postdoctoral Research Foundation of China [2018M632154]
  3. Natural Science Foundation of Zhejiang Province [LY19H270006, LQ19H080001]
  4. Traditional Chinese Medical Administration of Zhejiang Province [2022ZX005, 2022ZB119, 2021ZB090]
  5. Zhejiang Medical and Health Science and Technology Project [2021KY222]
  6. Research Project of Zhejiang Chinese Medical University [2021JKZDZC02, 2021JKZKTS036A, 2021JKJNTZ022B, 2019ZG25, 2018ZR06]
  7. National Undergraduate Innovation and Entrepreneurship Training Program [202110344005, 202110344025, S202110344007, 202010344004]
  8. General Research Project of Zhejiang Provincial Education Department Special Project for the Reform of Cultivation Mode of Professional Degree Graduate Students in Higher Education Institutions [Y202145932]
  9. Postgraduate Science Research Fund of Zhejiang Chinese Medical University [2021YKJ02, 2020YKJ07]

向作者/读者索取更多资源

Through network pharmacology analysis, the key targets and pathways of LWDHD in treating IVDD were verified, with animal experiments showing that LWDHD not only restored the disc height reduction and abnormal matrix metabolism degradation in IVDD mice, but also inhibited apoptosis and ameliorated the progression of IVDD.
Purpose: To explore the pharmacological mechanisms of Liuwei Dihuang Decoction (LWDHD) against intervertebral disc (IVD) degeneration (IVDD) via network pharmacology analysis combined with experimental validation. Methods: First, active ingredients and related targets of LWDHD, as well as related genes of IVDD, were collected from public databases. The protein-protein interaction (PPI) network, Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) functional enrichment analyses were performed to predict the core targets and pathways of LWDHD against IVDD. Secondly, the IVDD model of mice treated with LWDHD was selected to validate the major targets predicted by network pharmacology. Results: By searching the intersection of the active ingredient targets and IVDD targets, a total of 110 targets matched the related targets of 30 active ingredients in LWDHD and IVDD were retrieved. PPI network analysis indicated that 17 targets, including Caspase-3, IL-113, P53, etc., were hub targets. GO and KEGG enrichment analyses showed that the apoptosis pathway was enriched by multiple targets and served as the target for in vivo experimental study validation. The results of animal experiments revealed that LWDHD administration not only restored the decrease in disc height and abnormal degradation of matrix metabolism in IVDD mice but also reversed the high expression of Bax, Caspase-3, IL-113, P53, and low expression of Bcl-2, thereby inhibiting the apoptosis of IVD tissue and ameliorating the progression of IVDD. Conclusion: Using a comprehensive network pharmacology approach, our findings predicted the active ingredients and potential targets of LWDHD intervention for IVDD, and some major target proteins involved in the predictive signaling pathway were validated experimentally, which gave us a new understanding of the pharmacological mechanism of LWDHD in treating IVDD at the comprehensive level.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据